(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-(4-hydroxyMethyl-piperidin-1-yl)-Methanone
![]() |
- $400 - $469
- Product name: (2,3-Dihydro-benzo[1,4]dioxin-2-yl)-(4-hydroxyMethyl-piperidin-1-yl)-Methanone
- CAS: 1178713-03-5
- MF: C15H19NO4
- MW: 277.32
- EINECS:
- MDL Number:
- Synonyms:(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-(4-hydroxyMethyl-piperidin-1-yl)-Methanone;(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxyMethyl)piperidin-1-yl)Methanone;Methanone, (2,3-dihydro-1,4-benzodioxin-2-yl)[4-(hydroxymethyl)-1-piperidinyl]-
3 prices
Selected condition:
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerAlichem
- Product number1178713035
- Product description(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone
- Packaging1g
- Price$400
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM159589
- Product description(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone 95%
- Packaging1g
- Price$439
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11340131
- Product description(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone 95+%
- Packaging1g
- Price$469
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1178713035 | (2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone | 1g | $400 | 2021-12-16 | Buy |
Chemenu | CM159589 | (2,3-dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone 95% | 1g | $439 | 2021-12-16 | Buy |
Crysdot | CD11340131 | (2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone 95+% | 1g | $469 | 2021-12-16 | Buy |
Properties
Boiling point :475.7±45.0 °C(Predicted)
Density :1.250±0.06 g/cm3(Predicted)
pka :14.94±0.10(Predicted)
Density :1.250±0.06 g/cm3(Predicted)
pka :14.94±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|